SCHEME 2a
radical-mediated reduction of a bridgehead R-chloro amine as
key steps has been described.
Experimental Section
2-[Benzyl-(2,4-dimethoxy-benzyl)-amino]-propane-1,3-diol (7).
To a solution of 6 (3.0 g, 32.967 mmol) in MeOH (165 mL) was
added 2,4-dimethoxybenzaldehyde (5.473 g, 32.967 mmol) at room
temperature, and the mixture was stirred for 1 h. Na(OAc)3BH
(9.785 g, 46.154 mmol) was added in one portion. The solution
was stirred at room temperature for 5 h and treated with silica gel
(27 g). The slurry was concentrated to powder and purified by flash
chromatography (5%-15% MeOH (7 N NH3)/DCM) to give 6.990
g (89%) of the amino diol: 1H NMR (300 MHz, CDCl3) δ 7.11
(d, J ) 8.2 Hz, 1H), 6.45 (d, J ) 2.4 Hz, 1H), 6.42 (dd, J ) 2.4,
8.2 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.74 (s, 2H), 3.67 (dd, J )
4.8, 11.2 Hz, 2H), 3.53 (dd, J ) 5.1, 11.2 Hz, 2H), 3.06 (br, 3H),
2.72 (quint, J ) 2.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 160.3,
158.6, 130.5, 120.0, 103.9, 98.7, 61.8, 58.7, 55.3, 55.3, 46.0; HRMS
(ESI) calcd for C12H20NO4 (M + H) 242.1387, found 242.1387.
To a solution of the amino diol (6.99 g, 29.247 mmol) in DCM
was added benzaldehyde (3.41 g, 32.172 mmol) and acetic acid
(1.7 mL, 29.247 mmol) at room temperature, and the mixture was
stirred for 1 h. Na(OAc)3BH (8.681 g, 40.946 mmol) was added in
one portion, and the solution was stirred at room temperature for
1 day. Additional portions of benzaldehyde (1.55 g, 14.624 mmol)
and Na(OAc)BH (4.34 g, 20.473 mmol) were added, and the
resulting mixture was stirred for another day. Solvent was removed
in vacuo, and the residue was partitioned between ethyl acetate
and 1 N NaOH. After the organic layer was separated, the aqueous
layer was extracted with ethyl acetate three times. The combined
organic layers were dried over MgSO4. After concentration, the
residue was purified by flash chromatography (0-60% acetonitrile
(containing 1% 7 N NH3 in MeOH)/DCM) to give 7.262 g (76%)
of 7: 1H NMR (400 MHz, CDCl3) δ 7.24 (m, 5H), 7.08 (d, J )
8.0 Hz, 1H), 6.43 (m, 2H), 3.81 (s, 3H), 3.78 (s, 3H), 3.77 (s, 2H),
3.75 (s, 2H), 3.73 (dd, J ) 8.3, 11.1 Hz, 2H), 3.57 (dd, J ) 5.5,
11.1 Hz, 2H), 2.99 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 160.4,
158.8, 139.7, 132.0, 128.8, 128.2, 126.9, 119.2, 104.2, 98.8, 60.5,
59.8, 55.3, 55.3, 53.8, 48.8; HRMS (ESI) calcd for C19H26NO4 (M
+ H) 332.1856, found 332.1858.
a DMB ) 2,4-dimethoxybenzyl.
SCHEME 3
Benzyl-(2,4-dimethoxy-benzyl)-(7-methylene-[1,5]dioxocan-3-
yl)-amine (8). To a solution of tetrabutylammonium iodide (279
mg, 0.757 mmol) and NaH (333 mg, 8.327 mmol) in DMF (65
mL) at 50 °C was slowly added a solution of 7 (1.253 g, 3.785
mmol) and 3-chloro-2-chloromethyl-1-propene (473 mg, 3.785
mmol) in THF (15 mL) by a syringe pump over 1 h. The solution
was stirred for 1 hour and quenched with aqueous NaHCO3. The
mixture was partitioned between ethyl acetate and aqeous NaHCO3.
After the organic layer was separated, the aqueous layer was
extracted with ethyl acetate three times. The combined organic
layers were dried over MgSO4. After concentration, the residue was
purified by flash chromatography (0-40% ethyl acetate/hexane)
to give 664 mg (46%) of 8: 1H NMR (400 MHz, CDCl3) δ 7.31
(m, 2H), 7.25 (m, 3H), 7.17 (m, 1H), 6.43 (dd, J ) 8.3, 2.5 Hz,
1H), 6.39 (d, J ) 2.2 Hz, 1H), 5.12 (s, 2H), 4.13 (d, J ) 12.9 Hz,
2H), 4.06 (d, J ) 12.9 Hz, 2H), 3.88 (dd, J ) 12.0, 6.8 Hz, 2H),
3.77 (s, 3H), 3.76 (dd, J ) 12.0, 6.8 Hz, 2H), 3.75 (s, 3H), 3.72 (s,
2H), 3.62 (s, 2H), 2.99 (m, 1H); 13C NMR (100 MHz, CDCl3) δ
159.6, 158.6, 146.2, 140.7, 130.4, 128.3, 128.0, 126.5, 120.4, 118.5,
104.1, 98.2, 75.1, 68.5, 58.0, 55.3, 55.2, 54.8, 48.2; HRMS (ESI)
calcd for C23H30NO4 (M + H) 384.2169, found 384.2171.
iminium ion intermediate. Thus, reduction under radical condi-
tions was investigated. The hydroxyl group was converted to
chloride 11 using thionyl chloride at reflux,9 and tributylstan-
nane-mediated reduction10 of chloride 11 smoothly provided the
benzyl-protected amine 12. The final deprotection was carried
out under Pd black-HCO2H conditions11 to give 1 as a formic
acid salt. The structure was confirmed by both NMR analysis
and X-ray crystallography (Supporting Information).
The pKa of 1 was determined to be 6.7 by standard titration.
This attenuation in basicity of 1.7 pKa units with respect to
morpholine (pKa ) 8.4)12 is consistent with an additive inductive
effect of the second â-oxygen to the morpholine backbone in 1
(Scheme 3).
In summary, a synthesis of 3,7-dioxa-9-aza-bicyclo[3,3,1]-
nonane involving transannular hemi-aminal formation and
(9) (a) Mukaiyama, T.; Yanagisawa, M.; Iida, D.; Hachiya, I. Chem. Lett.
2000, 6, 606. (b) Kitching, M. S.; Clegg, W.; Elsegood, M. R. J.; Griffin,
R. J.; Golding, B. T. Synlett 1999, 997.
(10) Bachi, M. D.; Frolow, F.; Hoornaert, C. J. Org. Chem. 1983, 48,
1841.
(11) Fleet, G. W. J.; Ramsden, N. G.; Molyneux, R. J.; Jacob, G. S.
Tetrahedron Lett. 1988, 29, 3603.
(12) Hall, H. K. J. Am. Chem. Soc. 1957, 79, 5441.
7-[Benzyl-(2,4-dimethoxy-benzyl)-amino]-[1,5]dioxocan-3-
one (9). To a solution of 8 (1.868 g, 4.877 mmol) in THF-H2O
(20 mL/5 mL) was added OsO4 (2.5%, 1.2 mL, 0.0975 mmol) and
NMO (628 mg, 5.365 mmol) at room temperature, and the mixture
was stirred for 10 h. The solution was concentrated and filtered
through a small pad of silica gel to give 1.52 g (75%) of the diol.
414 J. Org. Chem., Vol. 71, No. 1, 2006